Can Borrelia infection cause cross-reactive immune responses, while antibody positivity reflects prior exposure and a negative blood PCR does not rule out infection?

Borrelia testing requires interpretation by clinical syndrome and timing rather than any single result. The strongest parts of the claim concern the limits of serology and blood PCR; molecular mimicry is a credible but more limited mechanistic finding.

Clinical testing evidence

• Positive Borrelia antibodies do not establish active infection. IDSA/AAN/ACR guidance indicates that IgG and IgM can persist for years to decades after infection, including after successful treatment. In cohorts assessed 10–20 years after prior Lyme disease, validated two-tier reactivity persisted despite no current active disease. Isolated IgM is particularly vulnerable to misinterpretation; CDC guidance advises disregarding it when symptoms have lasted >30 days.
• Negative blood PCR does not rule out infection. Reported sensitivity is commonly only about 30–50% in some settings and 1–28% in verifiable neuroborreliosis. Thus, a negative result from one blood sample is non-exclusionary, particularly when the clinical presentation is otherwise compatible.
• Conversely, in an untreated person with symptoms lasting months to years, a negative Borrelia IgG essentially rules out Lyme disease except for uncommon circumstances such as impaired antibody production or laboratory error.

Mechanistic considerations

• Blood PCR’s limited yield has a biologically coherent basis: spirochetemia can be transient and very low, often <50 organisms/mL. Low copy number, specimen compartment effects (including platelet association), and human-DNA inhibition can leave microbial DNA below assay detection.
• Molecular mimicry is plausible in selected Lyme arthritis studies. HLA-DR4-restricted OspA-reactive CD4+ T cells recognized related human LFA-1 and other self-peptides in vitro. This demonstrates cross-reactive immune recognition, but does not establish common, systemic, or causative autoimmune disease; epitope spreading and inflammatory mechanisms may also contribute.

Bottom line

• The claim is substantially supported: antibody positivity may reflect past exposure, and negative blood PCR cannot reliably exclude Borrelia infection. Molecular mimicry is a plausible, subset-specific mechanism—not a proven general explanation for Lyme manifestations or persistent illness.